167 related articles for article (PubMed ID: 34562426)
1. Mast cells-derived exosomes worsen the development of experimental cerebral malaria.
Huang K; Huang L; Zhang X; Zhang M; Wang Q; Lin H; Yu Z; Li X; Liu XB; Wu Q; Wang Y; Wang J; Jin X; Gao H; Han X; Lin R; Cen S; Liu Z; Huang B
Acta Trop; 2021 Dec; 224():106145. PubMed ID: 34562426
[TBL] [Abstract][Full Text] [Related]
2. Malaria-derived exosomes exacerbate liver injury during blood stage of Plasmodium berghei infection.
Zhang X; Zhang M; Wang QR; Hou X; Zhou T; Liu J; Wang Q; Liu W; Liu X; Jin X; Liu Z; Huang B
Acta Trop; 2023 Mar; 239():106815. PubMed ID: 36608749
[TBL] [Abstract][Full Text] [Related]
3. Activation of Mast Cells Promote
Huang B; Huang S; Chen X; Liu XB; Wu Q; Wang Y; Li X; Li K; Gao H; Cen S; Lin R; Liu Z; Jin X
Front Cell Infect Microbiol; 2019; 9():322. PubMed ID: 31552201
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a murine model of cerebral malaria in KunMing mice infected with Plasmodium berghei ANKA.
Ding Y; Xu W; Zhou T; Liu T; Zheng H; Fu Y
Parasitology; 2016 Oct; 143(12):1672-80. PubMed ID: 27574013
[TBL] [Abstract][Full Text] [Related]
5. Neuroimmunological blood brain barrier opening in experimental cerebral malaria.
Nacer A; Movila A; Baer K; Mikolajczak SA; Kappe SH; Frevert U
PLoS Pathog; 2012; 8(10):e1002982. PubMed ID: 23133375
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 Treatment Induces an Experimental Cerebral Malaria-Like Syndrome in C57BL/6 Mice Infected with Plasmodium berghei NK65.
Martins YC; Freeman BD; Akide Ndunge OB; Weiss LM; Tanowitz HB; Desruisseaux MS
Am J Pathol; 2016 Nov; 186(11):2957-2969. PubMed ID: 27640146
[TBL] [Abstract][Full Text] [Related]
7. Neuregulin-1 attenuates experimental cerebral malaria (ECM) pathogenesis by regulating ErbB4/AKT/STAT3 signaling.
Liu M; Solomon W; Cespedes JC; Wilson NO; Ford B; Stiles JK
J Neuroinflammation; 2018 Apr; 15(1):104. PubMed ID: 29636063
[TBL] [Abstract][Full Text] [Related]
8. Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
Briquet S; Lawson-Hogban N; Boisson B; Soares MP; Péronet R; Smith L; Ménard R; Huerre M; Mécheri S; Vaquero C
Infect Immun; 2015 Jul; 83(7):2771-84. PubMed ID: 25916985
[TBL] [Abstract][Full Text] [Related]
9. Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier.
Nacer A; Movila A; Sohet F; Girgis NM; Gundra UM; Loke P; Daneman R; Frevert U
PLoS Pathog; 2014 Dec; 10(12):e1004528. PubMed ID: 25474413
[TBL] [Abstract][Full Text] [Related]
10. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.
Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878
[TBL] [Abstract][Full Text] [Related]
11. Pre-existing Schistosoma japonicum infection alters the immune response to Plasmodium berghei infection in C57BL/6 mice.
Wang ML; Cao YM; Luo EJ; Zhang Y; Guo YJ
Malar J; 2013 Sep; 12():322. PubMed ID: 24034228
[TBL] [Abstract][Full Text] [Related]
12. Cerebral Malaria Is Regulated by Host-Mediated Changes in
Cimperman CK; Pena M; Gokcek SM; Theall BP; Patel MV; Sharma A; Qi C; Sturdevant D; Miller LH; Collins PL; Pierce SK; Akkaya M
mBio; 2023 Apr; 14(2):e0339122. PubMed ID: 36852995
[TBL] [Abstract][Full Text] [Related]
13. Lipoxin A4 attenuates endothelial dysfunction during experimental cerebral malaria.
Souza MC; Pádua TA; Torres ND; Souza Costa MF; Candéa AP; Maramaldo T; Seito LN; Penido C; Estato V; Antunes B; Silva L; Pinheiro AA; Caruso-Neves C; Tibiriçá E; Carvalho L; Henriques MG
Int Immunopharmacol; 2015 Feb; 24(2):400-407. PubMed ID: 25576659
[TBL] [Abstract][Full Text] [Related]
14. Blood-cerebrospinal fluid barrier: another site disrupted during experimental cerebral malaria caused by Plasmodium berghei ANKA.
Ngo-Thanh H; Sasaki T; Suzue K; Yokoo H; Isoda K; Kamitani W; Shimokawa C; Hisaeda H; Imai T
Int J Parasitol; 2020 Dec; 50(14):1167-1175. PubMed ID: 32882285
[TBL] [Abstract][Full Text] [Related]
15. Perivascular Arrest of CD8+ T Cells Is a Signature of Experimental Cerebral Malaria.
Shaw TN; Stewart-Hutchinson PJ; Strangward P; Dandamudi DB; Coles JA; Villegas-Mendez A; Gallego-Delgado J; van Rooijen N; Zindy E; Rodriguez A; Brewer JM; Couper KN; Dustin ML
PLoS Pathog; 2015; 11(11):e1005210. PubMed ID: 26562533
[TBL] [Abstract][Full Text] [Related]
16. Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice.
Recuenco FC; Takano R; Chiba S; Sugi T; Takemae H; Murakoshi F; Ishiwa A; Inomata A; Horimoto T; Kobayashi Y; Horiuchi N; Kato K
Malar J; 2014 Dec; 13():487. PubMed ID: 25495520
[TBL] [Abstract][Full Text] [Related]
17. Minocycline prevents cerebral malaria, confers neuroprotection and increases survivability of mice during Plasmodium berghei ANKA infection.
Apoorv TS; Babu PP
Cytokine; 2017 Feb; 90():113-123. PubMed ID: 27865203
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria.
DellaValle B; Hempel C; Staalsoe T; Johansen FF; Kurtzhals JA
Malar J; 2016 Aug; 15(1):427. PubMed ID: 27554094
[TBL] [Abstract][Full Text] [Related]
19. A novel role for von Willebrand factor in the pathogenesis of experimental cerebral malaria.
O'Regan N; Gegenbauer K; O'Sullivan JM; Maleki S; Brophy TM; Dalton N; Chion A; Fallon PG; Grau GE; Budde U; Smith OP; Craig AG; Preston RJ; O'Donnell JS
Blood; 2016 Mar; 127(9):1192-201. PubMed ID: 26511133
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium tuberculosis Coinfection Has No Impact on Plasmodium berghei ANKA-Induced Experimental Cerebral Malaria in C57BL/6 Mice.
Blank J; Behrends J; Jacobs T; Schneider BE
Infect Immun; 2016 Feb; 84(2):502-10. PubMed ID: 26644378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
